This course covers the current and emerging diagnostic and treatment protocols for Multiple Sclerosis (MS). The learning outcomes include understanding risk factors, diagnostic criteria, treatment goals, and available therapies for MS. The course teaches about genetic and environmental risk factors, diagnostic challenges, FDA-approved treatments, progressive MS research, and the role of stem cell therapy. The teaching method involves a lecture format by a medical expert. The intended audience includes healthcare professionals, researchers, students, and individuals interested in learning about the latest advancements in MS diagnosis and treatment.
Overview
Syllabus
Intro
Disclosures
Risk Factors - Genetic
Risk Factors - Environmental
Modifiable Risk Factors - Smoking
Modifiable Risk Factors - Gut Microbiome
2017 McDonald Diagnostic Criteria - RRMS
Earlier Diagnosis = Earlier Treatment
Earlier Treatment = Better Outcomes
Goals of Therapy/Monitoring - NEDA
Neurofilament light chain (NFL)
Diagnostic Challenges
Diagnostic Accuracy - MOG antibody
Natural Hx - Inflammation to Degeneration
15 FDA Approved Treatments for RRMS
Better Therapies = Better Outcomes
1 FDA Approved Treatment for PPMS
Progressive MS Research
Therapies Support Mitochondria
Stem Cell Therapy
Taught by
Stanford Health Care
